- May 19
Cancer researchers team up against deadliest brain tumors in children
The scientists are studying how to use an emerging technology called focused ultrasound to fight diffuse midline glioma (DMG), one of the...
- May 11
Advanced immunotherapy treatment may hold promise for children with brain cancer
WEHI researchers have found promise in treating DIPG with an innovative new immunotherapy treatment, called CAR T therapy. Read more:...
- Apr 21
Clinical trial improves neurocognitive outcomes for childhood craniopharyngioma
Investigators from St. Jude Children’s Research Hospital found that proton therapy had efficacy similar to conventional photon therapy...
- Apr 20
Localized delivery of CAR T cells to treat children with brain tumors
Advancements in CAR T cell delivery and B7-H3 targeting enabled researchers to conduct an exploratory clinical trial to evaluate B7-H3...
- Mar 17
New study uncovers key culprit behind pediatric brain cancer metastasis
New research pinpoints a key cause of metastasis from an aggressive form of brain cancer in children and provides a potential new therapy...
- Mar 8
Safe to Skip Primary Tumor Boosts in Pediatric Germinomas
Primary tumor boosts — an extra dose of radiation specifically to the tumor bed — does not improve survival after chemotherapy and...
- Feb 10
Children’s Cancer Institute begins trial for childhood brain cancer therapy
The trial will use the child’s own immune system for specifically targeting the Diffuse Intrinsic Pontine Glioma. Read more:...
- Jan 31
Understanding How Childhood Brain Tumors Develop
A team of scientists has identified a new cell type implicated in the development of the most common type of malignant childhood brain...
- Jan 17
New drug combination may effectively treat often fatal childhood brain tumor
Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...
- Jan 12
New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...